Chengchi Chao

Title: Innovations in Cancer Treatment by Chengchi Chao

Introduction

Chengchi Chao is a notable inventor based in Guangdong, China. He has made significant contributions to the field of cancer research through his innovative patents. With a total of two patents to his name, Chao is recognized for his work in developing tumor antigen polypeptides that have potential applications in cancer diagnosis, prevention, and treatment.

Latest Patents

Chao's latest patents include the "Col14A1-derived tumor antigen polypeptide and use thereof." This patent provides a tumor antigen polypeptide with a specific amino acid sequence, along with a nucleic acid encoding the same. It also details the use of this polypeptide, nucleic acid, and related components in cancer treatment. Another significant patent is the "CACNA1H-derived tumor antigen polypeptide and use thereof," which similarly outlines a tumor antigen polypeptide and its applications in the diagnosis and treatment of cancers.

Career Highlights

Chengchi Chao is currently associated with Genoimmune Therapeutics Co., Ltd., where he continues to advance his research in immunotherapy. His work focuses on harnessing the immune system to combat cancer, making strides in the development of effective therapeutic strategies.

Collaborations

Chao collaborates with esteemed colleagues such as Yong Hou and Shuntao Luo, contributing to a dynamic research environment that fosters innovation in cancer therapies.

Conclusion

Chengchi Chao's contributions to cancer research through his innovative patents highlight the importance of continued advancements in medical science. His work not only enhances our understanding of tumor antigens but also paves the way for new therapeutic approaches in oncology.